Considering the oncogenic role of RACGAP1 in the malignant behaviors of bladder cancer cells, we inferred that RACGAP1 exerts cancer-promoting functions via the upregulation of p-STAT3 [28], active RhoA, and p-ERK1/2 [29]. Here, STAT3 is linked to urinary bladder carcinoma.